Steven Burrill is Director at DEPOMED INC (DEPO). They have made 5 open-market trades across 3 companies since 2007, most recently 2013-10-30.
CIK 0001198177
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $2.1M since 2007, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DEPO | SELL | 2011-05-12 | 2011-05-13 | $8.18 | $1.3M | -20.6% | +2.4% | +2.4% |
| TRGT | SELL | 2011-05-11 | 2011-05-12 | $23.88 | $789K | N/A | N/A | N/A |
| TRGT | SELL | 2011-05-10 | 2011-05-13 | $23.94 | $1.2M | N/A | N/A | N/A |
| DEPO | BUY | 2008-11-26 | 2008-12-01 | $1.54 | $61K | -20.6% | +2.4% | +2.4% |
| VRUS | BUY | 2007-05-02 | 2007-05-04 | $9.00 | $2.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.